View more in

Evaluating Adjuvant Immunotherapy Use in Resected Stage IB-IIIA NSCLC

targetedonc.com
 2021-06-11

Cover picture for the articleTina Cascone, MD, PhD, discusses the basis for conducting the phase 3 IMpower010 study. Tina Cascone, MD, PhD, assistant professor, in the Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the basis for conducting the phase 3 IMpower010 study (NCT02486718).

www.targetedonc.com

Comments / 0

Comments / 0